Companies · Healthtech

Moxe Health Corp

MADISON · Healthtech · refined from filed group “Other Technology

Diligence memoA one-page analyst read on Moxe Health Corp — recommendation, valuation, rhythm, risks.
$34.8M
Total raised · real
2
Rounds
6.2×
Latest step-up
Top 14%
Sector rank · raised
Series B
Latest stage · inferred · Fri May 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Moxe Health Corp looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 2.45× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era.
Dormant
  • Last raise 4.1 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Moxe Health Corp is one of 2138 Healthtech companies tracked from MADISON. By capital raised it ranks in the upper tier (ahead of 87% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
4
Investors (latest)
2022-05-20
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries A · 2016-09-19 Raised $4.8M (real) Modeled valuation $109M (est)$4.8M$109MSeries A2016Series B · 2022-05-20 Raised $30M (real) Modeled valuation $404M (est)$30M$404MSeries B2022+$30MCumulative $35M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$4.8M · 2016
Series B$30.0M · 2022

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$403.8M
Base estimate est.
$70.5M
Conservative case
$1.1B
Upside case
$166.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series A · modeled $108.8M · 2016-09-192016Series B · modeled $403.8M · 2022-05-202022
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
4.1 yr
Elapsed time used
4.1 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
68 mo
Avg between rounds
$6.1M/yr
Capital velocity
9.8 yr
On record since
2016
First round
2
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 7.8× above median
This company$34.8M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 1.6× above median
This company$30.0M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 12× above median
This company$403.8M
Sector median$33.8M

Raised more than 87% of sector peers (real $). Modeled value above 92% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #7 of 98.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)Casana Care, Inc. · Series B Raised $56.4M · modeled $607.4M (est)Mendel Health Inc. · Series B Raised $52.7M · modeled $570.4M (est)Bicycle Health Inc. · Series B Raised $61.4M · modeled $492.2M (est)Brave Health, Inc. · Series B Raised $38.6M · modeled $485.3M (est)Flume Health, Inc. · Series B Raised $35.9M · modeled $445.6M (est)Healthy America, LLC · Series B Raised $31.0M · modeled $435.5M (est)Kintsugi Mindful Wellness, Inc. · Series B Raised $25.0M · modeled $370.1M (est)Invoq Health, Inc. · Series B Raised $41.5M · modeled $362.2M (est)Folx Health, Inc. · Series B Raised $59.3M · modeled $355.4M (est)Recuro Health, Inc. · Series B Raised $44.2M · modeled $339.7M (est)Orchard Healthcare, Inc. · Series B Raised $34.8M · modeled $338.6M (est)Moxe Health Corp (this company) Raised $34.8M · modeled $403.8M (est)Moxe Health Corp
CompanyStageRaised · realValue · estvs peer med.
Casana Care, Inc.Series B$56.4M$607.4M3.68×
Mendel Health Inc.Series B$52.7M$570.4M3.45×
Bicycle Health Inc.Series B$61.4M$492.2M2.98×
Brave Health, Inc.Series B$38.6M$485.3M2.94×
Flume Health, Inc.Series B$35.9M$445.6M2.70×
Healthy America, LLCSeries B$31.0M$435.5M2.64×
Moxe Health Corp this companySeries B$34.8M$403.8M2.45×
Kintsugi Mindful Wellness, Inc.Series B$25.0M$370.1M2.24×
Invoq Health, Inc.Series B$41.5M$362.2M2.19×
Folx Health, Inc.Series B$59.3M$355.4M2.15×
Recuro Health, Inc.Series B$44.2M$339.7M2.06×
Orchard Healthcare, Inc.Series B$34.8M$338.6M2.05×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$4.8M2016-09-19$21.9M$108.8M90%
Series B$30.0M2022-05-20$166.7M$403.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$4.8M2016-09-19
    • First recorded raise — entered as Series A.
    • 3 investors on this round.
  2. Series B$30.0M2022-05-20
    • Raised again after 68 mo — slower than the ~14 mo sector norm.
    • Round 6.2× larger than the prior — scaling up.
    • 4 investors on this round.
Intelligence
2028 ~Q1
Modeled next raise · ~68mo cadence
$90.0M
Modeled next size est.range $58.5M$144.0M
6.2×
Last step-up
$6.1M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Kirk Nielsen12 other2022-05
Gary Kurtzman7 other2022-05
MICHAEL COYNE3 other2022-05
Thomas Schnettler2 other2022-05
Daniel Wilson1 other2016-09
Christopher Lahoud2022-05
Gary J. Kurtzman, M.D.2016-09
Michael Arce2022-05
Registry & provenance

Moxe Health Corp is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1686302
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Elligo Health Research, Inc.HealthtechSeries B$41.5M$495.7Mnetwork1 shared operator · same sector · same stage
Inari Medical, Inc.HealthtechSeries B$51.9M$669.2Mnetwork1 shared operator · same sector · same stage
Prognos Health Inc.HealthtechSeries B$63.4M$235.0Mnetwork1 shared operator · same sector · same stage
Okami Medical, Inc.HealthtechSeries B$77.2M$125.4Mnetwork1 shared operator · same sector · same stage
Monteris Medical US, Inc.HealthtechSeries B$82.5M$168.0Mnetwork1 shared operator · same sector · same stage
Orchard Healthcare, Inc.HealthtechSeries B$34.8M$338.6Msame sector · same stage
Keystone Dental Holdings, Inc.HealthtechSeries B$34.7M$424.5Msame sector · same stage
Stride Health, Inc.HealthtechSeries B$34.5M$272.6Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Healthe, Inc.HealthtechSeries B$464.8M88%
Abax Health, Inc.HealthtechSeries A$14.6M86%
Oxos Medical, Inc.HealthtechSeries A$31.0M86%
Mochi Health Corp.HealthtechPre-Seed$9.5M85%
Hemex Health, Inc.HealthtechSeed$25.8M85%
Connexion Health LLCHealthtechSeed$62.4M85%
Motiv Health Inc.HealthtechPre-Seed$5.6M85%
McCoy Health, LLCHealthtechPre-Seed$8.6M84%
Frequently asked
How much funding has Moxe Health Corp raised?
Moxe Health Corp has raised approximately $34.8M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Moxe Health Corp's estimated valuation?
Provath's modeled valuation for Moxe Health Corp is approximately $403.8M (modeled range $70.5M–$1.1B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Moxe Health Corp at?
Moxe Health Corp's latest modeled financing stage is Series B. Its most recent recorded round closed around Fri May 20.
What does Moxe Health Corp do and where is it based?
Moxe Health Corp operates in the Healthtech sector, based in MADISON.
Explore related

See where Moxe Health Corp sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Moxe Health Corp, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.